Hereditary cancers require specialised genetic evaluation to determine whether an inherited mutation may be contributing to an individual's cancer risk. Apollo Adlux Hospital, Kochi offers Oncogenetics services for assessing hereditary cancer risk and supporting the clinical management of individuals and families with a potential genetic predisposition. Genetic assessment can be particularly relevant for selected patients with personal or family histories suggestive of inherited cancer syndromes.

BRCA1 and BRCA2 gene mutations are well-known examples associated with hereditary breast and ovarian cancer. Lynch syndrome represents another important hereditary cancer condition associated with an increased risk of colorectal cancer. Identification of an inherited cancer-predisposition gene mutation can provide valuable information for personalised surveillance and preventive healthcare planning.

Genetic counselling helps individuals understand their personal and family cancer history, assess the potential likelihood of hereditary cancer, and determine whether genetic testing may be appropriate. A positive hereditary cancer genetic test can lead to a personalised surveillance and prevention strategy. Enhanced screening may include more frequent mammography, breast MRI, or colonoscopy depending on the identified genetic risk.

Risk-reducing medications, preventive surgery, and genetic counselling for family members may also be considered based on the specific mutation and individual circumstances. Relatives who may carry the same inherited mutation can benefit from appropriate genetic evaluation.

Apollo Adlux Medical Genetics provides comprehensive oncogenetics support, combining hereditary cancer risk assessment, genetic testing guidance, result interpretation, surveillance planning, and family counselling.